HQL
abrdn Life Sciences Investors
HQL
HQL
45 hedge funds and large institutions have $54.3M invested in abrdn Life Sciences Investors in 2014 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 18 increasing their positions, 11 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
8% less funds holding
Funds holding: 49 → 45 (-4)
30% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 10
Holders
45
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$2.45M | |
| 2 | +$1.21M | |
| 3 | +$475K | |
| 4 |
NPC
National Planning Corporation
El Segundo,
California
|
+$459K |
| 5 |
Invesco
Atlanta,
Georgia
|
+$313K |
Top Sellers
| 1 | -$7.09M | |
| 2 | -$3.38M | |
| 3 | -$925K | |
| 4 |
Morgan Stanley
New York
|
-$800K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$650K |